Investing Profile

Rishi Gupta

InvestorVCAngel
Partner at OrbiMed
orbimed.comSan Francisco, California
Photo of Rishi Gupta, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
598 CONNECTIONS
OrbiMed Network
32 CONNECTIONS
OrbiMed Network
32 CONNECTIONS
OrbiMed Network
32 CONNECTIONS
Raymond James Network
25 CONNECTIONS
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
12
$18B
CompanyStageDateRound SizeTotal Raised
CHARM Therapeutics
Series BSep 2025$80M
Series AJun 2022$50M
$130M
Co-investors: Chris Bischoff (General Catalyst), Alex Morgan (Khosla Ventures), Muzammil Mansuri (F-Prime Capital Partners), Nihal Sinha (F-Prime Capital Partners)
Helicore Biopharma
Series AJan 2025$65M
$65M
Co-investors: Carlo Rizzuto (Versant Ventures)
Aer Therapeutics
Series AApr 2023$36M
$36M
Co-investors: Tim Shannon (Canaan Partners), Christy Shaffer (Hatteras Venture Partners)
Delfi Diagnostics
Series BJul 2022$230M
Series AJan 2021$100M
$330M
Co-investors: Greg Yap (Menlo Ventures), Justin Kao (DFJ Growth)
Enliven Therapeutics
Series ADec 2020$55M
SeedJan 2019
$55M
Co-investors: Mira Chaurushiya (Westlake Village BioPartners)
Modis Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Ben Auspitz (Forge Life Science Partners)
Attenua
Series AMay 2018$35M
$35M
Co-investors: Kurt von Emster (Abingworth)
Turnstone Biologics
Series BNov 2016$41M
$130M
Co-investors: Jerel Davis (Versant Ventures)
Corporate Finance Analyst Raymond JamesPresent
Manager, Corporate Development Veritas MedicinePresent
Summer Associate Wachtell, Lipton, Rosen & KatzPresent
Senior Associate OrbiMedPresent
Private Equity Principal OrbiMedPresent
Partner OrbiMedPresent
Harvard University AB Biochemical Sciences